{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:09:16Z","timestamp":1791425356297,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.leukres.2010.09.026","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T08:19:15Z","timestamp":1288253955000},"page":"431-437","source":"Crossref","is-referenced-by-count":9,"title":["Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma"],"prefix":"10.1016","volume":"35","author":[{"given":"Ana","family":"Rivero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Rapado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 F.","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Montalb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"de O\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Paz-Carreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Canales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"S\u00e1nchez-Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Fern\u00e1ndez","family":"de Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de la Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.09.026_bib0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics","volume":"286","author":"Evans","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.leukres.2010.09.026_bib0010","first-page":"1113","article-title":"Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review)","volume":"27","author":"Van den Neste","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1073\/pnas.90.2.431","article-title":"Genomic structure and chromosomal localization of the human deoxycytidine kinase gene","volume":"90","author":"Song","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2010.09.026_bib0020","doi-asserted-by":"crossref","first-page":"49901","DOI":"10.1074\/jbc.M305085200","article-title":"Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity","volume":"278","author":"Ge","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2010.09.026_bib0025","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1172\/JCI117841","article-title":"Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines","volume":"95","author":"Chen","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2010.09.026_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2210-4-8","article-title":"Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene","volume":"4","author":"Galmarini","year":"2004","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0035","first-page":"2389","article-title":"Resistance to 1-beta-d-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene","volume":"52","author":"Owens","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2010.09.026_bib0040","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V96.4.1517","article-title":"High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia","volume":"96","author":"Veuger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.09.026_bib0045","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1124\/dmd.108.020925","article-title":"Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics","volume":"36","author":"Kocabas","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.leukres.2010.09.026_bib0050","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.bcp.2003.07.008","article-title":"In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine","volume":"66","author":"Gamberale","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cncr.22740","article-title":"Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma","volume":"110","author":"Sacchi","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.09.026_bib0060","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2004.07.170","article-title":"Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma","volume":"22","author":"Zinzani","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0065","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.20234","article-title":"Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies","volume":"100","author":"Tam","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.09.026_bib0070","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2006-04-016725","volume":"108","author":"Forstpointner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.09.026_bib0075","first-page":"25","article-title":"Phase III Trial of Fludarabine Plus Cyclophosphamide compared with Fludarabine for patients with previously untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997","author":"Flinn","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2008.17.2619","article-title":"Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia","volume":"27","author":"Foon","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2008.16.4459","article-title":"Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses","volume":"27","author":"Lamanna","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0090","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW. WHO Classification of Tumours. IARC WHO Classification of Tumours, vol. 3."},{"key":"10.1016\/j.leukres.2010.09.026_bib0095","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0100","unstructured":"Poland Melt Program. http:\/\/www.biophys.uni-duesseldorf.de\/local\/POLAND\/poland.html."},{"key":"10.1016\/j.leukres.2010.09.026_bib0105","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.leukres.2010.09.026_bib0110","series-title":"Arlequin: A software for population genetics data analysis Ver 2.000","author":"Schneider","year":"2002"},{"key":"10.1016\/j.leukres.2010.09.026_bib0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00008571-200411000-00007","article-title":"Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients","volume":"14","author":"Shi","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.leukres.2010.09.026_bib0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0065-2571(93)90009-3","article-title":"Regulation of human deoxycytidine kinase expression","volume":"33","author":"Mitchell","year":"1993","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.leukres.2010.09.026_bib0125","first-page":"371","article-title":"Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity","volume":"1","author":"Kroep","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.leukres.2010.09.026_bib0130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bcp.2005.12.007","article-title":"The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia","volume":"71","author":"Lotfi","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0135","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1074\/jbc.M512129200","article-title":"Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Ser-74 in the control of enzyme activity","volume":"281","author":"Smal","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2010.09.026_bib0140","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/jpet.107.128595","article-title":"Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants","volume":"323","author":"Lamba","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.leukres.2010.09.026_bib0145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bcp.2004.05.007","article-title":"Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2\u2032-2\u2032-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000","volume":"68","author":"Al-Madhoun","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2353\/jmoldx.2009.080110","article-title":"High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms","volume":"11","author":"Rapado","year":"2009","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.leukres.2010.09.026_bib0155","doi-asserted-by":"crossref","DOI":"10.1007\/s00122-008-0870-8","article-title":"High resolution melting analysis of almond SNPs derived from ESTs","author":"Wu","year":"2008","journal-title":"Theor Appl Genet"},{"key":"10.1016\/j.leukres.2010.09.026_bib0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00228-006-0162-7","article-title":"Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers","volume":"62","author":"Joerger","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0165","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1124\/dmd.108.023184","article-title":"Differential allelic expression in leucoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3 and TP53","volume":"36","author":"Jordheim","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.leukres.2010.09.026_bib0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0959-8049(94)00435-8","article-title":"Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues","volume":"31A","author":"Spasokoukotskaja","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2010.09.026_bib0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2007.01.013","article-title":"Positive regulation of deoxycytidine kinase activity by phosphorylation of Ser-74 in B-cell chronic lymphocytic leukaemia lymphocytes","volume":"253","author":"Smal","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2010.09.026_bib0180","first-page":"3672","article-title":"Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF\/CEM\/0 and CCRF\/CEM\/dCk-1","volume":"47","author":"Antonsson","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2010.09.026_bib0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcp.2004.02.031","article-title":"Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells","volume":"68","author":"Smal","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2010.09.026_bib0190","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1038\/nprot.2007.420","article-title":"Measurement of cell proliferation by heavy water labeling","volume":"2","author":"Busch","year":"2007","journal-title":"Nat Protoc"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610004741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610004741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T10:45:17Z","timestamp":1592045117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610004741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0145212610004741"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.09.026","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}